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ABSTRACT OF THESIS

A COMPARISON BETWEEN MASTICATORY MUSCLE AND
TEMPOROMANDIBULAR JOINT PAIN PATIENTS WITH REGARD TO THE
PREVALENCE AND IMPACT OF POST-TRAUMATIC STRESS DISORDER
SYMPTOMS.
The purpose of this study was to evaluate masticatory muscle (MM) and
temporomandibular joint (TMJ) pain patients regarding the prevalence of Posttraumatic Stress Disorder (PTSD) symptoms, and evaluate the level of
psychological dysfunction and its relationship to PTSD symptoms in these
patients. This study included 445 adult patients (male = 42, female = 403).
Psychological questionnaires included the Symptom Check List-90-Revised
(SCL-90-R), the Multidimensional Pain Inventory, the Pittsburgh Sleep Quality
Index and the PTSD Check List Civilian. The total sample of patients was divided
into two major groups: The MM group (n=242) and TMJ group (n=203). Each
group was divided into three subgroups according to the presence of a stressor
and severity of PTSD symptoms. Thirty six patients (14.9%) in the MM group and
20 patients (9.9%) in the TMJ group presented symptomatology of PTSD. MM
and TMJ pain patients in the “positive PTSD” subgroups scored higher on all
scales of the SCL-90-R (p = .000) than the other two subgroups and reached
levels of distress that were indicative of psychological dysfunction. MM and TMJ
pain patients in the “positive PTSD” subgroups were more often classified as
dysfunctional than as adaptive copers and presented with more sleep
disturbances than patients in the “no stressor” and “negative PTSD” subgroups.
A somewhat elevated prevalence rate for PTSD symptomatology was found in
the MM than in the TMJ group. Significant levels of psychological dysfunction
appear limited to temporomandibular disorder patients with symptoms of PTSD.
KEYWORDS: Prevalence, TMD, PTSD, psychological dysfunction, sleep
disturbances.
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Chapter 1. Introduction
Post-traumatic Stress Disorder (PTSD) is defined as a type of anxiety
disorder that can develop following an individual’s exposure to an event
perceived to be threatening or traumatic according to the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV)1, see Table 1. As a
consequence of such exposure, a person may develop a recurring pattern of
symptoms. These symptoms include persistent re-experiencing of the traumatic
event, nightmares, recurrent and intrusive recollections, avoidance of the
situations associated with the traumatic event, sleeplessness, and hypervigilance
that must be present for more than one month 1. Post-traumatic Stress Disorder
can be classified as acute, when symptoms are present between one and three
months or chronic when symptoms last for three months or more. Finally, PTSD
can be classified as delayed onset when at least six months have passed
between the traumatic event and the onset of the disorder. Post-traumatic Stress
Disorder may coexist with others psychological disorders 2,
chronic

pain

conditions

such

as

fibromyalgia

4

,

5

,

3

and also with

headache

6

and

temporomandibular disorder (TMD) 7, 8.
Temporomandibular disorders (TMDs) comprise a number of clinical
problems involving the masticatory muscles and/or the temporomandibular joint
(TMJ) joint
and anxiety

9

that also have been associated with elevated levels of depression

10 11 12 13

,

,

,

. Studies comparing the two most common categories of

TMD, masticatory muscle (MM) pain and TMJ/intracapsular pain, revealed that
MM pain patients are more psychologically distressed than TMJ pain patients

1

14

,

15

,

16

,

17

. In general, psychological distress has been linked to increased pain

level in a number of investigations 4, 12, 18, 19, 20.
Anxiety disorders, such as PTSD, may have the potential to magnify the
subjective perception of pain

21

. Several studies have examined the relationship

between PTSD and chronic pain 5,18,

22

,

23

,

24

,

25

,. For instance, Sherman et al

found in a sample of fibromyalgia patients that pain level, disability and affective
distress was greater in those patients reporting PTSD symptoms than those who
did not report such symptoms 4. There are a small number of investigations
reporting the comorbidity of PTSD and TMD 7, 8,

19

. A recent investigation in

chronic orofacial pain patients revealed that the patients who reported symptoms
of PTSD were more psychologically distressed and more prone to be classified
with a dysfunctional profile than patients who did not report symptoms of PTSD
19

. An additional finding of this investigation was that clinically significant levels of

psychological distress are strongly linked with PTSD. It also has been reported
that traumatic experiences and more PTSD symptoms were observed in MM
pain patients compared to TMJ pain patents

17

,

26

. Apparently, the coexistence

and interaction of chronic pain/ TMD and PTSD is related to an increased
psychological distress, elevated levels of pain and greater disability. Such
characteristics may influence a patient’s adaptability to disease and treatment
outcomes. Consequently, the successful management of patients with chronic
pain/TMD requires assessment of comorbid psychological conditions. Thus,
screening for PTSD should be included as part of a TMD patient’s evaluation.

Copyright © 2005, Elizangela Bertoli
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Table1. Diagnostic Criteria for PTSD, DSM-IV1.
A

The person has been exposed to a traumatic event in which both of the following were present :

1

The person experienced, witnessed, or was confronted with an event or events that involved actual or
threatened death or serious injury, or a threat to the physical integrity of self or others

2

The person’s response to the event involves intense fear, helplessness or horror

B

The traumatic event is persistently re-experienced in one (or more) of the following ways:

1

Recurrent and intrusive distressing recollections of the event, including images, thoughts, or perceptions

2

Recurrent distressing dreams of the event

3

Acting or feeling as if the traumatic event were recurring (includes a sense of reliving the experience,
illusions, hallucinations, and dissociative flashback episodes, including those that occur on awakening or
when intoxicated)

4

Intense psychological distress at exposure to internal or external cues that symbolize or resemble an
aspect of the traumatic event

5

Psychological reactivity on exposure to internal or external cues that symbolize or resemble an aspect of
the traumatic event

C

Persistent avoidance of stimuli associated with the trauma and numbing of general responsiveness (not
present before the trauma), as indicated by three (or more) of the following:

1

Efforts to avoid thoughts, feeling, or conversations associated with the trauma

2

Efforts to avoid activities, places, or people that arose recollections of the trauma

3

Inability to recall an important aspect of the trauma

4

Markedly diminished interest or participation in significant activities

5

Feelings of detachment or estrangement from others

6

Restricted range of affect (e.g., unable to have loving feelings)

7

Sense of foreshortened future (e.g., does not expect to have a career, marriage, children, or normal life
span)

D

Persistent symptoms of increased arousal (not present before the trauma), as indicated by two (or more)
of the following:

1

Difficulty falling or staying asleep

2

Irritability or outbursts of anger

3

Difficulty concentrating

4

Hypervigilance

5

Exaggerated startle response

E

Duration of the disturbance (symptoms in criteria B,C, and D) is more than one month

F

The disturbance causes clinically significant distress or impairment in social, occupational or other
important areas of functioning

PTSD: Post-traumatic Stress Disorder.
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders-IV.

3

Chapter 2. Purpose of the Study
The aim of this investigation was to evaluate differences between MM pain
patients and TMJ pain patients who sought treatment at the Orofacial Pain
Center in the University of Kentucky with regard to the prevalence of PTSD
symptoms. A second aim of this study was to analyze the level of psychological
dysfunction and its relationship in regard to the presence and impact of PTSD
symptoms in MM pain patients and TMJ pain patients. We hypothesized that the
prevalence of PTSD symptoms would be higher in MM pain patients than in TMJ
pain patients. In addition, given the complicated nature of PTSD symptoms we
hypothesized that the presence of this symptomatology would influence the level
of psychological dysfunction in MM and TMJ pain patients in several domains.

Copyright © 2005, Elizangela Bertoli
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Chapter 3. Review of the Literature
3.1. Temporomandibular Disorders
3.1.2. Temporomandibular Disorders and Psychological Distress

According to the Research Diagnostic Criteria

27

, TMDs are divided in two

main categories: MM pain and TMJ (intracapsular) pain. Regarding etiology,
TMD is often considered complex and multifactorial in nature. Factors such as
trauma, constant deep pain input, orthopedic instability, parafunctional activities,
systemic factors and emotional stressors have been implicated in the etiology of
TMD

28

. Dworkin and LeResche

27

pointed out the importance of adding to the

Axis I which, comprises the physical conditions responsible for the etiology of
pain, a psychological aspect, the so called Axis II in the diagnosis of TMD. Axis II
involves the psychological condition and its effects in producing and/or
influencing the whole pain experience.
Several lines of evidence have linked TMD and psychological distress
29

,

30

11

,

. For instance, elevated levels of depression and anxiety are common

findings in TMD patients compared with healthy controls

10

,

16

,

31

,

32

,

33

,

34

.

Psychological distress is more often associated with MM pain patients than TMJ
pain patients

14

,

15

,

17

. In fact, MM pain patients report elevated levels of

depression, pain disability and exposure to major life stressors when compared
to intracapsular pain patients

20

,

35

. Major life stressors in turn have been

associated with high levels of pain, affective distress and disability in TMD

5

patients

20

. Lampe et al

36

noted that stressful life events such as childhood

abuse and depression experienced by chronic pain patients had a significant
impact on the occurrence of the chronic pain condition. In regard to TMD, Curran
et al

12

reported that 68.9% of orofacial pain patients reported a history of

physical and sexual abuse in an anonymous survey. The history of abuse was
significantly correlated to depression, psychological distress and greater pain
severity. There is also evidence suggesting that TMD patients suffer stressful life
events prior to the onset of their symptomatology

20 37 38

,

,

. Overall, traumatic life

experiences seem to interfere with the well-being of patients and may have a
substantial link to the occurrence of TMDs.
The activity of the sympathetic portion of the autonomic nervous system is
increased by emotional stress. This is the so called stress response or “fight or
flight” response which is characterized by an increase in the arterial blood
pressure, blood flow to muscles, muscle activity and mental activity

39

. Although,

this increased autonomic activity is normal for acute stressors, major life events
and/or persistent chronic stressors may also have long term consequences for
an individual depending on how s/he perceives a situation and her/his general
state of physical health 40. McEwen in 1998 described these consequences as an
increased activity of the “allostatic systems” (autonomic nervous, cardiovascular,
metabolic and immune systems and hypothalamic-pituitary-adrenal (HPA) axis),
the allostatic load theory, that may result in chronic overactivity of these systems
40

. It is known, for example, that chronic emotional stress may produce pain and

increase its severity by precipitating and increasing activity in the central nervous

6

and musculoskeletal systems

41

. In addition, it has been demonstrated that there

is increased cardiovascular activity and altered breathing rate in chronic TMD
patients compared to normal controls 34.
An additional response to a stressor is the activation of the HPA-axis in
response to stimulation of the sympathetic nervous system. This activation
releases catecholamines that stimulate the secretion of corticotrophin-releasing
factor (CRF) from the hypothalamus. Corticotrophin-releasing factor then induces
the secretion of adrenocorticotropin hormone (ACTH), from the pituitary gland. It,
in turn, mediates the release of cortisol from the adrenal cortex. This sequence of
events that culminates in an increase of cortisol levels is a normal and ordinary
response to any type of acute stress (physical or mental). The acute increase in
cortisol is of significant benefit because glucocorticoids cause rapid mobilization
of aminoacids and fats making them available for energy and for synthesis of
other compounds

39

. However, chronic activation of the HPA-axis can cause

pathophysiologic consequences such as down-regulation of the hippocampal
glucocorticoid receptors and toxicity to hippocampal neurons leading to cognitive
impairment that can alter memory 42, 43, 44.
Dysregulation of the HPA-axis has been related to several psychological
disorders as well as to stress-related bodily disorders. In fact, hyperactivity of the
HPA-axis that produces high levels of cortisol is an ordinary finding in affective
disorders such as depression

13 45 46

,

,

. In contrast to affective disorders, stress-

related bodily disorders like chronic fatigue syndrome and fibromyalgia are
characterized by hypocortisolism

46

,

7

47

,

48

,

49

. In addition, hypocortisolism has

been found in other somatoform disorders such as rheumatoid arthritis and
asthma

50

. Indeed, hyporesponsiveness of the HPA-axis is associated with

increased inflammatory cytokines
reported in animal studies

52

51

and its consequences have also been

. The animals in these studies were very susceptible

to autoimmune and inflammatory disturbances 52.
It also appears that dysregulation of the HPA-axis plays an important role
in chronic pain and may actually predispose vulnerability for the development of
chronic pain 50. With TMDs, however, inconsistent findings have been reported in
the neuroendocrinologic investigations. For instance, Jones et al in 1997
analyzing TMD patients and a control group noted that the TMD group was
heterogeneous in regard to the levels of cortisol released in response to stress.
The authors found TMD patients with increased cortisol levels and TMD patients
whose cortisol levels were not different from healthy controls

53

. Other

investigation revealed hypercortisolism in a group of 15 women with TMD
patients compared to a control group

54

. Even though the patients were initially

screened for psychological disorders, three subjects presented with symptoms of
major depression. Interestingly, the methodology included the assessment of
cortisol by plasma levels. It has been speculated that cortisol levels may fluctuate
as a result of transient stressors in the environment including the actual stress of
venipuncture or anticipatory anxiety associated with venipuncture

55

. Overall the

findings suggest that chronic pain disorders including TMD potentially are related
to dysregulation of the HPA-axis.

8

3.1.3. Temporomandibular Disorders and Sleep Disturbance

From the available literature, it is currently unknown whether chronic pain
conditions produce a sleep disturbance or whether a sleep disturbance is
significant in the initiation of the chronic pain condition itself. According to
Okeson, sleep disturbances may be a systemic perpetuating factor that can
cause the progression of an acute muscle pain to a chronic pain condition 28. The
available literature reveals a strong relationship between sleep problems and
chronic pain. Poor sleep quality has been linked to chronic pain conditions
58

,

59

56 57

,

,

. The deeper stages of sleep are important to restore function of the body

systems such as the metabolic process. In fact, Moldofsky and Scarisbrick in
1976 noted that stage-four deprivation led to musculoskeletal symptoms such as
muscle tenderness and stiffness in healthy subjects, but such symptoms were
not observed following disruption of the rapid eye-movement (REM) sleep

60

. It

appears that deprivation of the deeper stages of sleep may result in muscle pain
because of the inability of an individual to repair damaged tissues. Patients with
TMD frequently report sleep disturbance

61 62 63

,

,

. In regard to the two categories

of TMD, patients in the MM pain category report more sleep disturbances
compared to patients in the TMJ pain category

17 64

,

. In addition, in TMD patients

the sleep disturbance is related to elevated levels of pain severity and
psychological distress 16, 30.

9

3.1.4. Summary

From the aforementioned review it is apparent that there is a positive
relationship between TMD and emotional stressors. This relationship may disturb
the well-being of the patient and may impact her/his ability to cope with the
illness. Sleep disturbances often coexist with TMD and may be considered a
contributing factor that may play an important role in the individual’s recovery.
Although, inconsistent findings of the neuroendocrinologic investigations have
been reported in the literature, it seems that like in many other pain conditions,
TMD is associated with dysregulation of the HPA-axis.

3.2. Post-traumatic Stress Disorder (PTSD)

Symptoms of PTSD have been reported in victims following rape
motor vehicle accident
conditions

70

,

71

22

,

67

,

68

terrorist attacks

69

, combat veterans experiences
72

,

73

and natural disasters

74

65

,

66

,

, medical

. Based on

community studies, the lifetime prevalence of PTSD ranges from 1% to 14% 1.
Reports of at-risk individuals (e.g. combat veterans, survivors of natural
disasters, terrorist attacks or criminal violence) revealed prevalence rates raging
from 3% to 58% 1, 72, 75, 76.
Considering chronic pain patients, several lines of evidence suggest a
high prevalence of PTSD symptoms in such patients 4, 5,

18

,

24

,

77

. In addition,

PTSD co-occurs with other psychiatric diagnosis such as mood, anxiety and

10

substance abuse disorders. In fact, one study showed that approximately 80% of
PTSD patients met criteria for at least one other psychiatric disorder

2

.

Depression is the most widely investigated comorbid disorder 3. For example,
Hickling et al in 1992 analyzing headache patients who were victims of motor
vehicle accident meeting diagnostic criteria for PTSD, noted that major
depression was also present among those patients 22. The literature documenting
a positive relationship between PTSD and substance abuse is also extensive
79 80 81 82

,

,

,

78

,

. Indeed, recent studies noted a high prevalence of cigarette smoking

in patients with current PTSD symptoms

83

,

84

. The authors suggested a link

among anxiety, PTSD, and substance abuse.
Dysregulation of the HPA-axis is a common finding in patients reporting
symptoms of PTSD. Although inconsistent findings have been reported in the
literature regarding cortisol levels in PTSD patients
to be linked to hypocortisolism

46

,

55

,

85

,

86

55

, there is a trend for PTSD

. The inconsistent findings could be

attributed to differences in the methodological assessment used in the studies.
An additional factor that could contribute to these differences is the coexistence
of others psychiatric disorders, such as depression, which may influence the
findings since depression has been associated with hypercortisolism

87

. It seems

that a variation of the psychiatric symptomatology over time in PTSD patients
may also influence cortisol levels. In addition, the time frame between the trauma
suffered by an individual and the investigation may also affect cortisol findings

55

.

For example, there may be a difference in cortisol levels during or immediately
after the traumatic event as compared to years after the traumatic event. It has

11

been reported that early life stressors may result in a persistent sensitization of
the HPA-axis to stressors in adulthood 46. It also has been suggested that chronic
PTSD is associated with increased negative feedback inhibition of cortisol, due to
altered glucocorticoid receptor activity

88

. Symptoms of PTSD such as increased

response to stress, hypervigilance and arousal are consistent with dysregulation
of the HPA-axis 88.

3.2.1. PTSD and Sleep Disturbances

Sleep disturbances are included in the symptomatology of PTSD
according to the DSM-IV 1. They are included in the category of re-experiencing
symptoms, for example, nightmares, and in the category of arousal that
contributes to difficulty falling or staying asleep. Sleep disturbances and
nightmares are part of a normal and typical response following traumatic or
threatening trauma

89

. However, for some individuals the sleep disturbance

becomes a persistent problem. For instance, in a study of the survivors of the
Oklahoma City bombing, 70% of the survivors reported sleep disturbance six
months following the event

90

. In addition, sleep problems were the most

common symptom reported by survivors of natural disaster

91

, war prisoners

92

and holocaust victims 93.
The majority of the studies reporting association between sleep
disturbances and PTSD used subjective measures such as self-reported
symptoms, questionnaires and medical interviews

12

94

. Symptoms most frequently

reported by PTSD patients are difficulty falling or staying asleep, shorter sleep
duration, restless sleep, daytime fatigue and nightmares

95

,

96

. Such sleep

disturbances may exacerbate symptoms of PTSD. In fact, several research
groups have reported the clinical importance of the sleep disturbance’s treatment
in PTSD patients

97

. A causal relationship between sleep disturbance and PTSD

has not yet been reported. Harvey et al in 2003 critically assessed the evidence
on the prevalence and treatment of sleep disturbance of patients with PTSD.
They concluded that there is a clear association between PTSD and sleep
problems. However, the role sleep disturbances play in the mechanism of PTSD
is unclear

89

. In other words, further studies are needed to determine whether a

causal relationship between sleep disturbance and PTSD exists.

3.2.2. Summary

Following exposure to a traumatic or threatening incident an individual
may develop symptoms of PTSD. According to the literature, PTSD has been
linked to other psychiatric disorders such as depression and anxiety as well to
chronic pain disorders. In addition, a positive relationship exists between PTSD
and substance abuse and sleep disturbances. Similar to TMD, PTSD has been
associated with dysregulation of the HPA-axis.

3.3. TMD and PTSD

13

Few studies have investigated the relationship between TMD and PTSD.
Evidence reporting a high prevalence of PTSD symptoms in orofacial pain
patients comes from clinical data 7, 8,

19

. Several lines of evidence suggest a

higher prevalence of PTSD symptoms in the MM pain category compared to the
TMJ pain category

17

,

19

,

26

. Aghabeigi in 1992 found that 15% of patients with

chronic idiopathic pain had a history of PTSD which coincided with the pain onset
7

. Sherman et al in 1998 found a PTSD prevalence rate of 23% in chronic face

pain patients 8. In this study, patients with symptoms of PTSD reported higher
levels of pain, greater affective distress and less control over their lives than
patients without PTSD symptoms. Similarly, de Leeuw et al in 2005 also noted
increased pain severity, affective distress and disability among orofacial pain
patients with symptomatology of PTSD. A persistent finding in orofacial pain
patients

19

, headache patients

98

and neuropathic pain patients

99

is that the

presence of PTSD symptoms may dictate elevated levels of psychological
distress in several domains.
The findings with regard to pain level, affective distress and disability for
TMD patients with PTSD symptoms are in accord with previous publications in
chronic pain. For example, Geisser et al in 1996 demonstrated that chronic pain
patients with elevated PTSD symptoms reported increased pain and affective
distress

18

. In addition, Sherman and colleagues in 2000 evaluated a sample of

fibromyalgia patients with and without symptomatology of PTSD noted higher
level of pain, emotional distress, life interference and disability among patients
reporting PTSD symptoms as compared to patients who did not report symptoms
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of PTSD 4. A common characteristic of patients with symptoms of PTSD and
chronic pain is that these patients present with difficulty in coping and adapting to
their pain 4,

19

. These patients are also frequently classified as dysfunctional or

interpersonally distressed 4,

19

,
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, on the MPI profile classification. The same

tendency is observed in TMD, and seems to be more pronounced in muscle pain
patients than in patients with primarily joint pathology 17, 64.
Based on this review, it seems that TMD, especially the MM pain
category, and PTSD exhibit common symptoms such as depression, anxiety,
sleep disturbances and dysregulation of the HPA-axis. In fact an overlap of
symptoms between chronic pain in general and PTSD has been observed in the
literature

23

. Asmundson et al in 2002 discussed two mechanisms that may

explain the co-occurrence of these disorders, the shared vulnerability hypothesis
and the mutual maintenance hypothesis. For the shared vulnerability hypothesis,
an anxiety disorder may be a predisposing factor for both conditions, thereby
increasing the susceptibility for development of both conditions

23

. Considering

the mutual maintenance mechanism that was first introduced by Sharp and
Harvey in 2001

101

, it is proposed that characteristics of either chronic pain or

PTSD may reciprocally maintain or exacerbate the symptoms of the other
disorder. It is postulated that for PTSD patients, chronic pain provides a
persistent reminder of the trauma, thus in such patients an attentional bias
towards the pain experience may exacerbate the pain condition. Furthermore,
pain sensation may be exacerbated by high levels of anxiety. In addition,
depression may maintain the symptomatology of PTSD and chronic pain. In
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summary, the mutual maintenance hypothesis is based on the following
mechanisms generated by distress: 1) attentional and reasoning biases; 2)
anxiety sensitivity; 3) reminders of the trauma; 4) avoidance; 5) depression and
reduced activity levels; 6) anxiety and pain perception and 7) cognitive demand
from symptoms limiting use of adaptive strategies. The persistence of these
factors may lead to disability.
A third mechanism that would confirm the coexistence of chronic pain and
PTSD is the fear-avoidance model. Fear and avoidance may occur in response
to chronic pain and may also be a symptom of PTSD

102

. In chronic pain, fear-

avoidance occurs in response to the avoidance of movement that would increase
pain sensation. In general, physiological symptoms such as increased blood flow,
heart rate, or muscle tension may increase pain sensation and emphasize fear
towards activities that will result in avoidance of such activities

103

. For PTSD, a

characteristic symptom is the fear of thinking about or talking about the stressful
experience, a symptom that would culminate in avoidance of activities or
situations associated with the traumatic experience. In addition, Otis et al in 2003
discussed the triple vulnerability model as a fourth hypothesis linking the
coexistence of chronic pain and PTSD
characterized

by

a

generalized

102

. The triple vulnerability model is

biological

vulnerability,

a

generalized

psychological vulnerability and a more specific psychological vulnerability. Keane
and Barlow in 2002 adapted this model to propose a hypothesis for the
development of PTSD

104

. They suggested that in order to develop PTSD one

must develop anxiety and an unpredictable and uncontrolled emotional reaction
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to an event that resembles the traumatic event. Thus, when negative affect and
the sense of uncontrollability are present, PTSD may develop. Otis et al in 2003
102

proposed an extrapolation of this model to chronic pain whereby the pain

experience itself could be perceived as an unpredictable and uncontrollable
sensation leading to a lack of personal control over the pain. This in turn may
lead to feelings of low self-efficacy, negative affect and avoidance of daily life
situations. In summary, four models have been presented linking chronic pain
and PTSD. The relationship between chronic pain and PTSD may have
implications in treatment outcome for both conditions.

3.3.1. Summary

A high prevalence of PTSD in chronic pain patients including TMD
patients is a common finding in the epidemiological studies. Chronic pain patients
with PTSD symptoms frequently report higher levels of pain, affective distress
and disability than chronic pain patients without PTSD symptoms. In addition,
chronic pain patients with symptomatology of PTSD are more often classified
with a dysfunctional profile than an adaptive coper profile on the MPI profile
classification and present with clinically significant psychological distress on
several domains. Due to the fact that both patients with chronic pain and patients
with PTSD present with common symptomatology such as depression, anxiety,
and/or dysregulation of the HPA-axis, an overlap of symptoms has been
proposed. These mutual characteristics as proposed in four mechanisms
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described above may influence prognostic and treatment outcomes of chronic
pain patients with symptoms of PTSD.

3.4. PTSD, TMD and Treatment Outcomes

The effectiveness of biobehavioral strategies for management of TMD has
been evaluated in a number of studies

105 106

,

. In fact, biobehavioral approaches

such as proprioceptive awareness training, relaxation, diaphragmatic breathing
training and awareness and control of parafunctional activities have been
indicated for short and long term management of TMDs, especially those with
MM pain as the primary symptom

107

. Similarly, psychological approaches are

currently identified as a first choice for treatment of PTSD

108

. Psychological

treatments for PTSD include exposure therapy, which was first used by Black
and Keane

109

to treat PTSD among combat veterans. Anxiety management that

involves relaxation training, breathing retraining, trauma education, cognitive
restructuring, or communication skill training can also have a favorable impact on
the

symptoms

of

PTSD

110

.

In

addition

to

psychological

treatment,

pharmacotherapy for PTSD has also been suggested 111. In a recent report, Stein
and

coworkers

systematically

reviewed

randomized

controlled

trials

of

pharmacotherapy for PTSD and concluded that medication should be considered
as part of the treatment of PTSD. Although they could not demonstrate
differences among classes of medication with regard to efficacy or better
tolerance, the largest trials showing efficacy were those evaluating selective
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serotonin re-uptake inhibitors. In addition, glucocorticoids (hydrocortisone)

112

and propranolol 113 have been suggested to prevent development of PTSD.
Regarding the coexistence of the two conditions, management of chronic
pain patients with symptoms of PTSD should include treatment directed to the
anxiety disorder and the pain disorder. In fact, simultaneous treatment of chronic
pain and PTSD has been suggested in the literature4,

23

. In view of the fact that

chronic pain and PTSD may exacerbate each other’s symptoms, management
accomplishment of chronic pain patients with PTSD symptoms may be
compromised. For example, depression in chronic pain patients has been
associated with poor treatment response
treatment

115

114

and prematurely abandoning

. In addition, a dysfunctional profile has been related to poor

treatment outcome in TMD patients

15

. It seems logical that addressing all

coexistent factors in both disorders may potentially lead to favorable treatment
outcome, although further studies are necessary to determine whether it is
necessary to address both conditions simultaneously in order to observe
patient’s improvement in general. Perhaps addressing one of the two conditions
or even one aspect these conditions have in common such as depression and/or
anxiety or sleep disturbances could be sufficient to have a positive treatment
outcome in both chronic pain and PTSD.
Unfortunately, only a small number of studies addressing treatment
outcome in chronic pain patients with PTSD symptoms have been reported in the
literature. For instance, Hickling et al noted that patients with post-traumatic
headache meeting criteria for PTSD required significantly longer cognitive
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behavioral treatment than controls

116

. Recently, a case study evaluating the

effects of PTSD treatment in chronic pain patients was reported

117

. The patient

sample was composed of six females not responding to standard pain
interventions such as surgery, physical therapy and medication including
selective serotonin re-uptake inhibitors, non-steroids antiinflammatory and
anticonvulsants. The PTSD treatment included a number of psychological
approaches such as imaginal and in vivo exposure, relaxation techniques, social
support, anger management and pleasant event scheduling. The authors found
reduction in PTSD symptoms, improvement in dysfunction associated with pain,
such as working status and time spent in bed following treatment. There was,
however, no subjective reduction in pain reported by the subjects.

3.4.1. Summary

Addressing all coexisting factors may be the key to successful treatment in
chronic pain patients with symptoms of PTSD. Behavioral treatment seems to be
a promising approach for both chronic pain and PTSD. In fact, it appears that
targeting PTSD symptoms may improve treatment outcomes overall in chronic
pain patients. Additionally, educational strategies aimed at increasing patients’
recognition of the potential association between PTSD and chronic pain may be
helpful as well. However, the effect of such treatment has not been
systematically evaluated. Further investigations are needed to evaluate long-term
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treatment outcome and whether decreasing symptoms of PTSD has a positive
effect in the treatment response of chronic pain patients.
Based on the aforementioned review of literature, the purpose of this
study was to evaluate differences between MM pain patients and TMJ pain
patients who sought treatment in an orofacial pain center in regard to the
prevalence of PTSD symptoms. A second aim of this study was to analyze the
level of psychological dysfunction and its relationship in regard to the presence
and impact of PTSD symptoms in MM pain patients and TMJ pain patients. We
hypothesized that the prevalence of PTSD symptoms and the level of
psychological distress would be higher in MM pain patients than in TMJ pain
patients. In addition, given the complicated nature of PTSD symptoms we
hypothesized that the presence of this symptomatology would influence the level
of psychological dysfunction both in MM and TMJ pain patients in several
domains.

Copyright © 2005, Elizangela Bertoli

21

Chapter 4. Experimental Design and Methods
4.1. Participants

This study was a retrospective analysis of psychometric and sleep
disorders data obtained from patients during the initial visit at an orofacial pain
clinic as part of a standard evaluation protocol. The patient sample was selected
from patients seen at the Orofacial Pain Center at the University of Kentucky,
College of Dentistry from 1997 to 2005. Patients with both a primary and
secondary diagnosis of MM pain or both a primary and secondary diagnosis of
TMJ pain according to the Research Diagnostic Criteria
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were eligible to

participate in this study. Patients with a single diagnosis of either MM pain or
TMJ pain were also eligible. Patients with a primary diagnosis of TMJ pain and a
secondary diagnosis of MM pain or vice versa were not eligible. As part of the
Orofacial Pain Center protocol all participants already have signed the standard
“Patient Registration/Consent form” upon arriving for their initial evaluation.
All patients completed an orofacial pain questionnaire and a battery of
psychological questionnaires as part of the initial evaluation/examination. The
psychological questionnaires included the Symptom Check List-90-Revised
(SCL-90-R)

118

, the Multidimensional Pain Inventory (MPI)

Sleep Quality Index (PSQI)

120

119

, the Pittsburgh

and the PTSD Check list Civilian (PCL-C)

121

.

These questionnaires embrace an extensive variety of symptoms and behaviors
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that are important tools to develop a thorough treatment/management plan for
chronic pain patients.
The Orofacial Pain Center initial evaluation/examination involves an
extensive interview where a detailed patient’s history is taking followed by
conduction of clinical examination. The main objective of the history-taking is to
acquire an accurate description of the patient’s chief complaint; information about
key elements of each complaint(s), including onset, location, intensity, duration
and associated factors is obtained. In addition, a psychologic assessment is also
obtained. The clinical examination is composed of physical measures such as
blood pressure and pulse rate, cranial nerve examination, cervical evaluation,
muscle palpation with special emphases on myofascial trigger points and pain
referral, TMJ evaluation (palpation, loading, joints sounds, deviation and
deflection), range of mandibular movement and an intraoral examination. For this
study the examinations were performed by dentists with advanced training in the
diagnosis of orofacial pain conditions. All examiners were trained in the Orofacial
Pain Center of the University of Kentucky within the guidelines of the American
Academy of Orofacial Pain 9.
The total sample of patients was divided into two major groups:
Masticatory muscle (MM) and temporomandibular joint (TMJ) group. The MM
group comprised patients with a primary and, when given, a secondary diagnosis
of masticatory muscle pain

27

. The TMJ group comprised patients with a primary

and, when given, a secondary diagnosis of TMJ/intracapsular pain

27

.

Subsequently, each group was divided in three subgroups according to the
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presence of a reported stressor (s) and severity of PTSD symptoms. The
diagnoses of PTSD symptoms were based on the PCL-C, which corresponds to
the DSM-IV criteria for PTSD (Table 2). Both groups were subcategorized as “no
stressor”, “negative PTSD symptoms”, “positive PTSD symptoms” according to
the presence of stressor and degree of PTSD symptomatology reported on the
PCL-C. A score of 41 is considered the cut-off point for clinical significance of
PTSD symptomatology

122

. The “no stressor” group comprised patients who did

not report a stressor on the PCL-C. The “negative PTSD symptoms” group
comprised patients who reported one or more stressor(s) on the PCL-C but did
not meet criteria for PTSD symptoms (PCL-C score < 41). The “positive PTSD
symptoms” group comprised patients who reported one or more stressor(s) on
the PCL-C and met criteria for PTSD symptoms (PCL-C score ≥ 41).

4.2. Inclusion Criteria

Patients who presented with the following characteristics were included in the
study:
1. At least18 years of age.
2. A single diagnosis of TMJ or MM pain or, when a secondary diagnosis was
given, both primary and secondary diagnoses of either MM or TMJ pain
according to the Research Diagnostic Criteria.
3. Pain duration of at least three months.
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4. Pain intensity of at least three on visual analogue scale.
5. No stressor reported on the PCL-C for inclusion in the “no stressor” subgroup.
6. Stressor(s) reported and PCL score < 41 for inclusion in the “negative PTSD
symptoms” subgroup.
7. Stressor(s) reported and PCL-C score ≥ 41 for the inclusion in the “positive
PTSD symptoms” subgroup.

4.3. Psychometric Measures

For this study data from the SCL-90-R, MPI, PSQI and PCL-C were used.
The SCL-90-R is a 90–item self–report inventory that is used to assess
psychological symptoms and yield nine symptoms dimensions and three global
indices of functioning. Patients were asked to rate each item on a 5-point scale
(from 0 “not at all” to 4 “extremely”) for how much each item has distressed or
bothered them during the last 7 days including the day of the examination. From
the SCL-90-R the presence and extent of symptoms such as somatization,
obsessive-compulsive, interpersonal sensitivity, anxiety, depression, hostility,
phobic anxiety, paranoid ideation, and psychoticism were obtained. The reliability
and validity of the SCL-90-R has been demonstrated in a great number of studies
summarized by Derogatis in 1983

123

. Test-retest reliabilities range from r = 0.78

to 0.90 for non-patient samples, and internal consistencies range from 0.77 to
0.90 118.
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The MPI includes three sections and contains 61 questions, which
furnishes data regarding pain severity, perceptions of how pain interferes with
life, appraisal of the amount of support received from spouse or significant other,
perceived life control, affective distress including rates of depressed mood,
irritability, tension, and social and general activities. In addition, it provides a
patient profile classification, which includes dysfunctional, interpersonally
distressed and adaptive coper profiles. These three profiles are considered the
prototypic profiles. The category “Dysfunctional” comprises patients who report a
high level of pain, distress, and disability and who feel pessimistic and helpless
about their condition. The category “Interpersonally distressed” includes patients
with the same characteristics as “Dysfunctional” but who also report poor social
support. The category “Adaptive coper” includes patients who report low levels of
pain, disability, and distress. In addition, three other profile classifications may be
given. These include hybrid, anomalous and unanalyzable profiles. The “Hybrid”
profile represents a combination of prototypic profiles. The “Anomalous” profile
comprises MPI scale scores that make no sense to established theory; reasons
for such profile could be random responding, reading or responding difficulties, or
faking bad or good. Finally, the “Unanalyzable” profile is given when data are
missing, and therefore, statistical analyses of the scores are not possible. Kerns
et al
119

119

have demonstrated the validity of the MPI across chronic pain patients

. Test–retest reliabilities range from r = 0.68 to 0.86 and internal consistencies

range from 0.73 to 0.90 119.
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The PSQI is an 18-item self-report measure used to appraise general
sleep quality. It provides information regarding the number of hours spent in bed
and asleep, sleep latency, frequency and reasons for awakening, difficulty
returning to sleep after awakening, sleep efficiency and use of sleep medication.
The PSQI has demonstrated test–retest stability (r = 0.85) and internal
consistency (alpha= 0.83) and provides valid and reliable assessment to overall
sleep quality and disturbance 120, 124.
The PCL-C is a 17-item self-report measure, used to assess the incidence
of significant stressor(s) and prevalence of PTSD symptomatology. Before
completing the 17-item measure, the patient is asked to identify any significant
stressors s/he has experienced on a 15-item experience list. The list includes
military combat, violent attack, being kidnapped, taken hostage, terrorist attack,
torture, incarceration, natural or man-made disaster, severe auto accident, being
diagnosed with a life-threatening illness, sudden injury/serious accident,
observed someone hurt or killed, learned that your child has a life-threatening
illness, and “others”. Subsequently, the patient is asked to identify the most
significant stressor, indicate the date of occurrence and appraise how much the
most significant stressor has bothered her/him in the past month on the 17-item
measure. In this segment, 17 items are rated on a 5-point scale (1: “not at all”, 2:
“a little bit”, 3: “moderately”, 4: “quite a bit”, and 5 “extremely”; see table 2). The
PCL-C has exhibited test-retest stability (r = 0.96), good overall internal
consistency (alpha = 0.92), and provides a valid and reliable assessment of the
presence of PTSD symptoms 122.
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4.4 Statistics Analyses

Initial analyses were conducted by comparing the two diagnostic (MM and
TMJ) groups. Diagnostic, demographic, MPI profile, and prevalence of PTSD
symptomatology data between the two groups were tested using chi-square
analyses. Age, pain severity, and pain duration were tested using student’s ttests. After these initial comparisons, each diagnostic group was divided into
three

subgroups

depending

on

prevalence

and

intensity

of

PTSD

symptomatology (no stressor, negative PTSD symptoms and positive PTSD
symptoms subgroup). Analysis of variance ANOVA was used to test differences
between the two diagnostic groups and among the three subgroups with regard
to data from the SCL-90-R, MPI, and PSQI. The potential for family-wise error
due to multiple comparisons during ANOVA was controlled for by using the
Bonferroni correction. Significance level for all other comparisons was set at
p=.05. All statistical analyses were conducted using the Statistical Package for
the Social Sciences, Release 11.0 (SPSS Inc; Chicago, III).

Copyright © 2005, Elizangela Bertoli
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Table 2. The PTSD Checklist-Civilian Version (PCL-C) 125.
1
Repeated, disturbing memories, thoughts, or images of the stressful experience
2

Repeated, disturbing dreams of the stressful experience

3

Suddenly acting or feeling as if the stressful experience were happening again (as
if you were reliving it)

4

Feeling very upset when something reminded you of the stressful experience

5

Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when
something reminded you of the stressful event

6

Avoiding thinking about or talking about the stressful experience or avoiding
having feelings related to it

7

Avoiding activities or situations because they reminded you of the stressful
experience

8

Trouble remembering important parts of the stressful experience

9

Loss of the interest in activities that you used to enjoy

10

Feeling distant or cut-off from other people

11

Feeling emotionally numb or being unable to have loving feelings for those close
to you

12

Feeling as if your future somehow will be cut short

13

Trouble falling or staying asleep

14

Feeling irritable or having angry outbursts

15

Having difficulty concentrating

16

Being super alert, or watchful, or on-guard

17

Feeling jumpy or easily startled

PTSD: Post-traumatic Stress Disorder.
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Chapter 5. Results
5.1 Sample size, demographics characteristics, pain variables and
prevalence of PTSD symptoms

The total patient sample was comprised of 445 adult patients (male = 42;
female = 403; mean age 37.25 ± 12.9 years). The MM pain group was composed
of 242 patients (male = 23; female = 219) with a mean age of 38.27 ± 12.9 years.
The TMJ pain group was composed of 203 patients (male = 19; female = 184)
with a mean age of 36.0 ± 12.8 years. Pain severity measured by a visual
analogue scale where “0” is no pain and “10” is the most extreme pain, was 6.9 ±
1.9 and 6.4 ± 2.0 respectively for the MM group and TMJ group. Pain duration
reported by patients was 42.9 ± 55.7 months and 46.7 ± 74.5 months
respectively for the MM group and TMJ group. There were no significant
differences between the two groups in regard to gender (p=.55), age (p=.739),
pain severity (p=.053), pain duration (p=.108) and demographic characteristics
(see table 3).
Of the entire sample, 206 patients (46%; 48% of the MM group and 44%
of the TMJ group) reported to have experienced one or more significant traumatic
stressors. Fifty six patients (12.6%) of the total sample presented with
symptomatology of PTSD. More patients in the MM group (14.9%) than in the
TMJ group (9.9%), met criteria for PTSD symptoms, but the difference was not
statistically significant (p=.280; see table 4).
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In the MM group there were no significant differences among the three
subgroups (no stressor, negative PTSD and positive PTSD symptoms
subgroups) in regard to gender (p=.161), age (p=.384), pain severity (p=.986)
and pain duration (p=.935). Significant differences, however, were found in
smoking status (χ2=6.657; p=.036) and marital status (χ2 =18.961; p=.004) where
patients in the “positive PTSD subgroup” were more likely to be smokers,
divorced and less likely to be married than patients in the other two subgroups.
Additionally, patients in the “positive PTSD symptoms” were more likely to be
applying for or receiving disability than patients in the other two subgroups
(χ2=24.476; p=.000).
In the TMJ group there were no significant differences among the three
subgroups in regard to gender (p=.425), age (p=.331), pain severity (p=.074),
pain duration (p=.632) and smoking status (p=.125). Significant differences,
however, were found on marital status where patients in the “positive PTSD
subgroup” were more likely to be divorced and less likely to be married than
patients in the other two subgroups (χ2= 18.961; p=.004). Additionally, patients in
the “positive PTSD symptoms” were more likely to be applying for or receiving
disability than patients in the other two subgroups (χ2=24.476; p=.000).
With respect to the presence of a stressor and / or PTSD symptomatology,
there were no significant differences between the MM and TMJ group in the
“positive PTSD symptoms” subgroups in regard to gender (p=.288), age
(p=.634), pain severity (p=.631), pain duration (p=.513), disability (p=.566) and
demographic characteristics in general (p>.05). There were no significant
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differences between the MM and TMJ group in the “negative PTSD symptoms”
subgroup in regard to gender (p=.533), age (p=.462), pain severity (p=.063), pain
duration (p=.370), disability (p=.503) and demographic characteristics in general
(p>.05). There were also no significant differences between the MM and TMJ
group in the “no stressor” subgroup in regard to age (p=.124), gender, (p=.410),
pain duration (p=.632), disability (p=.052) and demographic characteristics in
general (p>.05). A significant difference however, was found between the MM
and TMJ groups in the “no stressor” in regard to pain severity with patients in the
MM group reporting more severe pain than patients in the TMJ group.(p=.007).

5.2 Psychometric Data
5.2.1 SCL-90-R

Analyses of SCL-90-R data revealed higher scores on all subscales for
patients in the MM group as compared to patients in the TMJ group, although
these differences were not statistically significant for most scales (see table 5
and figure 1). In the MM group, there were significant differences among the
three subgroups (p=.000) for all nine subscales of the SCL-90-R. Post hoc tests
revealed that these differences were due to significant higher scores on the
subscales in patients who reported a stressor and met criteria for PTSD
symptoms (“positive PTSD symptoms” subgroup) than in the other two
subgroups (see figure 2). The same pattern was observed for the TMJ subgroups
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(p=.000; see figure 3) for all subscales. Only patients in the “positive PTSD
symptoms” subgroups of both the MM and TMJ group reached levels of distress
that were indicative of psychological dysfunction on almost all subscales of the
SCL-90-R (T-Score ≥ 63; see figures 1, 2 and 3).
Considering the presence of a stressor and / or PTSD symptomatology,
there were no significant differences between the MM and TMJ group in the “no
stressor” subgroups on the SCL-90-R scales. A significant difference, however,
was found between the MM and TMJ groups in the “negative PTSD symptoms”
subgroups on the “phobic anxiety” subscale of the SCL-90-R (p=.016). In
addition, a significant difference was found between the MM and TMJ groups in
the “positive PTSD symptoms” subgroups on the “somatization” subscale of the
SCL-90-R (p=.010; see table 6).

5.2.2 MPI and MPI profile classification

Significant differences were found between the MM and TMJ groups on
most MPI scales. The MM group had significant higher scores on “interference”,
“affective distress” and “punishing responses” scales and presented with lower
scores on “life control”, “support”, “distracting responses”, “activities away from
home”, “social activities” and “general activities level” scales than the TMJ group
(see table 7).
In the MM group, there were significant differences among the three
subgroups for the following scales of the MPI: “interference”, “life control”,
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“affective distress”, “support” and “punishing responses” (see table 8). Post hoc
tests revealed that the “positive PTSD symptoms” subgroup had significantly
lower scores on the “life control” scale and significantly higher scores on the
“affective distress” and “punishing responses” scales than the other two
subgroups (see table 8). For the MPI scales “interference” and “support”
significant differences were found between the “no stressor” and “positive PTSD
symptoms” subgroup with patients in the “positive PTSD symptoms” subgroup
reporting more “interference” and less “support” than patients in the “no stressor”
subgroup (see table 8).
In the TMJ group, there were significant differences among the three
subgroups for the following scales of the MPI: “interference”, “life control”,
“affective distress”, “punishing responses”, “distracting responses”, “activities
away from home”, “social activities” and “general activity level” (see table 9). Post
hoc tests revealed that the “positive PTSD symptoms” subgroup had significantly
lower scores on the “life control”, “activities away from home”, “social activities”
and “general activity level” scales and significantly higher scores on the “affective
distress”, “punishing responses” and “distracting responses” scales than the
other two subgroups (see table 9).
Considering the presence of a stressor and / or PTSD symptomatology,
there were no differences between the MM and TMJ groups in the “positive
PTSD symptoms” subgroups. Significant differences however, were found
between the MM and TMJ groups in the “no stressor” as well as in the “negative
PTSD symptoms” subgroups with regard to three scales of the MPI with patients
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in MM group reporting more life interference and affective distress and less life
control (see table 10).
Approximately 50% of all patients were classified in one of the three main
MPI profiles. Significant differences were found between the MM group and the
TMJ group with regard to the MPI main profile classification (see table 11; the
three non-specific profiles were not analyzed). Patients in the MM group were
more often classified as dysfunctional or interpersonally distressed than patients
in the TMJ group.
In the MM group, the patients in the “positive PTSD symptoms” subgroup
were significantly more often classified as dysfunctional and patients in the “no
stressor” and in the “negative PTSD symptoms” subgroups were more often
classified as adaptive copers (see table 12).
In the TMJ group, the patients in the “no stressor” and in the “negative
PTSD symptoms” subgroups were more often classified as adaptive copers than
patients in the “positive PTSD symptoms” (see table 12).
Considering the presence of a stressor and / or PTSD symptomatology,
there were no significant differences between the MM and TMJ group in the
“positive PTSD symptoms” subgroups for the three MPI profile classifications
(see table 13). However, a significant difference was found between the
“negative PTSD symptoms” subgroups where patients in the MM group were
more often classified as interpersonally distressed than patients in the TMJ group
(see table 13). A significant difference was also found between the “no stressor”
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subgroups where patients in the MM group were more often classified as
dysfunctional than patients in the TMJ group (see table 13).

5.2.3 PSQI

Subjectively reported sleep problems were significant higher for the MM
group than for TMJ group (see table 14). In the MM group, the subgroup “positive
PTSD symptoms” reported more sleep problems on most scales of the PSQI
than the subgroups “no stressor” and “negative PTSD symptoms” (see table 15).
The same trends were seen with TMJ patients in the subgroup “positive PTSD
symptoms” who reported more sleep problems on all scales of the PSQI than
TMJ pain patients in the subgroups “no stressor” and “negative PTSD symptoms”
(see table 16).
There were no significant differences between the MM and TMJ groups in
the subgroups “positive PTSD symptoms” for any of the scales of the PSQI.
Significant differences, however, were seen between the MM and TMJ group in
the “no stressor” as well as in the “negative PTSD symptoms” subgroups on most
scales of the PSQI, with the MM group reporting more sleep-related problems
than the TMJ group (see table 17).
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Table 3. Demographic Characteristics.
Variable

MM Group
N (%)

TMJ group
N (%)

Chisquare

219 (90.5)

184 (90.6)

0.003

0.546

23(9.5)

19 (9.4)

Married

142 (59.9)

117 (62.6)

3.49

0.322

Single

57 (24.1)

51 (27.3)

Divorced

32 (13.5)

17 (9.1)

Widowed

6 (2.5)

2 (1.1)

Full time employment

117 (48.3)

98 (48.3)

6.78

0.341

Part time employment

28 (11.6)

21 (10.3)

Unemployed

32(13.2)

36 (17.7)

Disabled

27 (11.2)

15 (7.4)

Retired

11 (4.5)

8 (3.9)

Student

13 (5.4)

6 (3.0)

Receiving or applying for
disability

37(15.6)

22 (10.9)

2.08

0.095

Lawyer consult

18 (7.8)

9(4.6)

1.80

0.126

Smoker

64 (26.9)

51 (25.1)

0.18

0.378

Female
Male

MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
N: number of patients; %: percentage.
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Table 4. Prevalence of Stressors and PTSD Symptoms.
MM Group
TMJ Group

Total

N (%)

N (%)

No Stressor

126 (52.1)

113 (55.7)

239 (53.7)

Negative PTSD symptoms

80 (33.1)

70 (34.5)

150 (33.7)

Positive PTSD symptoms

36 (14.9)

20 (9.9)

56 (12.6)

PTSD: Post-traumatic Stress Disorder.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
N: number of patients; %: percentage.
2
(χ =2.547; p=.280)
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Table 5. SCL-90-R Symptom Dimension Means and Standard Deviations between MM and TMJ Groups.
MM Group
TMJ Group
F
SCL-90-R Subscales
p
M (SD)
M (SD)
Somatization
61.8 (9.0)
58.0 (10.1
2.536
0.112
Obsessive-compulsive

57.7 (11.4)

54.9 (11.9)

0.517

0.472

Interpersonal sensitivity

54.9 (11.2)

52.9 (10.9)

0.140

0.780

Depression

57.9 (10.9)

54.1 (10.7)

.000

0.999

Anxiety

55.9 (10.9)

53.3 (11.3)

0.487

0.486

Hostility

55.3 (10.1)

53.1 (9.9)

0.126

0.723

Phobic anxiety

50.9 (9.4)

50.7 (9.3)

.023

0.880

Paranoid ideation

51.8 (10.8)

49.5 (10.1)

1.323

0.251

Psychoticism

55.9 (10.6)

52.1 (9.7)

3.850

0.050*

SCL-90-R: Symptom Check List- 90-Revised.
MM: masticatory muscle; TMJ: temporomandibular joint.
M: Mean; SD: Standard Deviation.
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Table 6. Comparison of SCL-90-R Symptom Dimension Means and Standard Deviations between the MM and TMJ
Groups on a Subgroup Level.
SCL-90-R subscales
Trauma
MM Group
TMJ Group
F
p
Grouping
M(SD)
M(SD)
Somatization
No stressor
60.8 (8.3)
56.8 (9.5)
1.847
.175

Obsessive-compulsive

Interpersonal
sensitivity

Depression

Anxiety

Hostility

Phobic anxiety

Paranoid ideation

Psychoticism

Negative PTSD

60.5 (8.0)

56.7 (9.6)

1.897

.171

Positive PTSD

68.3 (10.9)

70.4 (7.1)

7.152

.010*

No stressor

56.0 (11.0)

53.2 (11.6)

1.122

.291

Negative PTSD

55.5 (10.8)

53.4 (10.2)

.815

.368

Positive PTSD

68.7 (7.8)

69.5 (8.5)

.272

.604

No stressor

54.0 (10.4)

52.3 (10.7)

.130

.718

Negative PTSD

51.5 (9.4)

50.7 (9.7)

.051

.821

Positive PTSD

65.8 (11.7)

64.4 (9.7)

.670

.417

No stressor

56.5 (10.8)

53.2 (10.7)

.007

.934

Negative PTSD

55.7 (9.5)

52.3 (9.5)

.126

.723

Positive PTSD

68.0 (8.9)

66.1 (6.4)

.533

.469

No stressor

54.8 (10.2)

52.1 (10.3)

.015

.901

Negative PTSD

52.6 (9.4)

51.3 (10.9)

3.845

.052

Positive PTSD

67.5 (9.7)

67.2 (9.3)

.297

.588

No stressor

53.5 (9.7)

52.6 (9.3)

.426

.514

Negative PTSD

53.5 ( 8.4)

51.1 (9.2)

.688

.408

Positive PTSD

65.8 (7.5)

63.7 (8.9)

.425

.517

No stressor

49.0 (7.9)

49.6 (8.3)

.385

.536

Negative PTSD

48.7 (6.6)

49.5 (8.9)

5.965

.016*

Positive PTSD

62.1 (12.0)

60.9 (9.8)

2.762

.102

No stressor

50.4 (9.5)

48.0 (8.8)

.358

.550

Negative PTSD

49.4 (8.9)

48.4 (9.3)

.015

.903

Positive PTSD

62.6 (12.6)

62.0 (11.5)

.683

.412

No stressor

54.0 (10.0)

51.1 (9.0)

2.990

.085

Negative PTSD

52.4 (8.5)

50.9 (8.2)

.246

.621

Positive PTSD

64.9 (11.7)

62.8 (11.5)

.049

.825

SCL-90-R: Symptom Check List- 90-Revised.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
M: Mean; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
*: Statistically significant.
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Table 7. Comparisons of MPI Scales Means and Standard Deviations between MM and TMJ Groups.
MPI Scale
MM Group
TMJ Group
F
p
M(SD)
M(SD)
Interference
33.6 (16.0)
25.0 (15.0)
30.142
.000*
Life control

49.4 (7.9)

53.0 (7.3)

26.405

.000*

Affective distress

47.4 (9.6)

43.5 (10.4)

27.082

.000*

Support

47.3 (11.1)

47.3 (10.0)

3.124

.045*

Punishing responses

46.5 (8.6)

45.0 (7.1)

10.998

.000*

Soliciting responses

49.9 (9.7)

48.1 (9.5)

.423

.655

Distracting responses

47.7 (9.7)

50.4 (40.2)

6.257

.002*

Household chores

55.7 (9.1)

55.6 (9.6)

1.394

.249

Outdoor work

54.6 (11.6)

54.1 (11.4)

.166

.847

Activities away from home

53.0 (10.0)

54. 2 (10.0)

5.114

.006*

Social activities

51.8 (10.0)

52.9 (9.4)

4.283

.014*

General activity level

55.2 (9.9)

55.9 (9.7)

2.743

.065

MPI: Multidimensional Pain Inventory.
MM: Masticatory Muscle; TMJ Temporomandibular Joint.
M: Means; SD: Standard Deviations.
*: Statistically significant.
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Table 8. Comparisons of MPI Scales Means and Standard Deviations among the Three Subgroups in the MM Group.
No stressor
Negative
Positive PTSD
MPI Scale
F
P
M(SD)
PTSD
M(SD)
M(SD)
Interference
31.7a (16.2)
33.9a,b (15.5)
39.4b (14.2)
3.382
.036*
a
a
Life control
50.2 (8.0)
50.7 (7.0)
43.8b (6.9)
11.842
.000*
a
46.7a (9.7)
53.9b (6.7)
10.464
.000*
Affective distress
46.0 (9.6)
Support
48.6 a (8.9)
47.3a,b (12.8)
42.5b(13.3)
3.299
.039*
a
45.7a (7.8)
51.5b (10.3)
5.690
.004*
Punishing responses
45.6 (8.0)
Soliciting responses
49.5 (8.8)
48.0 (10.9)
49.1 (10.2)
.422
.656
Distracting responses
48.2 (9.5)
47.0 (9.9)
47.5 (10.6)
.308
.735
Household chores
55.9 (8.7)
55.2 (9.8)
55.7 (9.4)
.172
.842
Outdoor work
53.6 (11.4)
56.5 (11.6)
53.8 (12.0)
1.601
.204
Activities away from home
54.0 (10.0)
52.0 (10.3)
51.4 (10.0)
1.415
.245
51.9 (10.2)
50.6 (9.7)
.301
.740
Social activities
52.0 (10.0)
General activity level
55.5 (9.4)
55.4 (10.6)
54.2 (10.3)
.240
.786
MPI: Multidimensional Pain Inventory.
MM: Masticatory Muscle.
M: Means; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
ab
When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between
group means at p≤.05
*: Statistically significant.
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Table 9. Comparisons of MPI Scales Means and Standard Deviations among the Three Subgroups in the TMJ
Group.
No stressor
Negative
Positive PTSD
MPI Scale
F
P
M(SD)
PTSD
M(SD)
M(SD)
Interference
23.3a (13.8)
23.7a (13.0)
39.6b (17.8)
11.962
.000*
a
a
Life control
53.3 (7.5)
53.9 (5.6)
47.5b (9.4)
6.532
.002*
Affective distress
42.5a (9.7)
42.5a (10.5)
53.4b (9.7)
10.794
.000*
Support
48.3 (9.4)
45.2 (11.2)
49.1 (8.6)
1.959
.144
a
45.3a (7.1)
50.3b (10.5)
5.628
.004*
Punishing responses
43.9 (6.0)
Soliciting responses
48.8 (10.2)
46.5 (8.6)
50.8 (8.0)
1.644
.196
a
46.4a (8.7)
50.5b (7.2)
5.825
.004*
Distracting responses
47.4 (8.7)
Household chores
56.3 (9.3)
55.5 (9.4)
52.2 (11.6)
1.608
.203
Outdoor work
53.4 (11.4)
56.5 (10.0)
52.9 (15.0)
.862
.424
a
55.0a (9.6)
47.4b (10.8)
5.296
.006*
Activities away from home
54.9 (9.8)
Social activities
53.8a (9.4)
53.3a (8.5)
46.9b (10.3)
4.870
.009*
a
a
56.7 (8.6)
50.0b (13.0)
4.147
.017*
General activity level
56.4 (9.3)
MPI: Multidimensional Pain Inventory.
TMJ: Temporomandibular Joint.
M: Means; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
ab
When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between
group means at p≤.05
*: Statistically significant.
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Table 10. Comparison of MPI Scales Means and Standard Deviations between MM and TMJ group on the
Subgroup Level.
MPI Scale
Trauma Grouping
MM Group
TMJ Group
F
p
M(SD)
M(SD)
Interference
No stressor
31.7 (16.2)
23.3 (13.8)
17.991
.000*

Life control

Affective distress

Support

Punishing responses

Soliciting responses

Distracting responses

Household chores

Outdoor work

Activities away from home

Social activities

General activity level

Negative PTSD

33.9(15.5)

23.7 (13.0)

18.765

.000*

Positive PTSD

39.4 (14.2)

39.6 (17.8)

.002

.961

No stressor

50.2 (8.0)

53.3 (7.5)

9.228

.003*

Negative PTSD

50.7 (7.0)

53.9 (5.6)

9.374

.003*

Positive PTSD

43.8 (6.9)

47.5 (9.4)

2.817

.099

No stressor

46.0 (9.6)

42.5 (9.7)

7.864

.005*

Negative PTSD

46.7 (9.7)

42.5 (10.5)

6.720

.010*

Positive PTSD

53.9 (6.7)

53.4 (9.7)

.054

.817

No stressor

48.6 (8.9)

48.3 (9.4)

.059

.808

Negative PTSD

47.3 (12.8)

45.2 (11.2)

.874

.352

Positive PTSD

42.5 (13.3)

49.1 (8.6)

2.989

.092

No stressor

45.6 (8.0)

43.9 (6.0)

2.728

.100

Negative PTSD

45.7 ((7.8)

45.3 (7.1)

.089

.767

Positive PTSD

51.5 (10.3)

50.3 (10.5)

.125

.725

No stressor

49.5 (8.8)

48.8 (10.2)

.282

.596

Negative PTSD

48.0 (10.9)

46.5 (8.6)

.781

.379

Positive PTSD

49.1 (10.2)

50.8 (8.0)

.293

.591

No stressor

48.2 (9.5)

47.4 (8.7)

.351

.554

Negative PTSD

47.0 (9.9)

46.4 (8.7)

.120

.729

Positive PTSD

47.5 (10.6)

50.5 (7.2 )

.922

.343

No stressor

55.9 (8.7)

56.3 (9.3)

.106

.745

Negative PTSD

55.2 (9.8)

55.5 (9.4)

.045

.833

Positive PTSD

55.7 (9.4)

52.2 (11.6)

1.498

.226

No stressor

53.6 (11.4)

53.4 (11.6)

.010

.921

Negative PTSD

56.5 (11.6)

55.6 (10.0)

.244

.622

Positive PTSD

53.8 (12.0)

52.9 (15.0)

.058

.811

No stressor

54.0 (10.0)

54.9 (9.8)

.486

.486

Negative PTSD

52.0 (10.3)

55.0 (9.6)

3.233

.074

Positive PTSD

51.4 (10.0)

47.4 (10.8)

1.994

.164

No stressor

52.0 (10.0)

53.8 (9.4)

1.797

.181

Negative PTSD

51.9 (10.2)

53.3 (8.5)

.880

.350

Positive PTSD

50.6 (9.7)

46.9 (10.3)

1.789

.187

No stressor

55.5 (9.4)

56.4 (9.3)

.556

.457

Negative PTSD

55.4 (10.6)

56.7 (8.6)

.655

.420

Positive PTSD

54.2 (10.3)

50.0 (13.0)

1.684

.200

MPI: Multidimensional Pain Inventory.
M: Mean; SD: Standard Deviation.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
PTSD: Post-traumatic Stress Disorder.*: Statistically significant.
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Table 11. MPI Profile Classification between the MM and TMJ Groups.
MPI profile
MM Group
TMJ Group
Chi-square
N (%)
N (%)
Dysfunctional
46 (34.8)
21 (24.7)
9.328

.002*

Interpersonally distressed

27 (20.5)

10 (11.8)

7.811

.005*

Adaptive coper

59 (44.7)

54 (63.5)

.221

.638

MPI: Multidimensional Pain Inventory
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
N: Number of patients, %: percentage
*: Statistically significant.
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Table 12. MPI Profile Classification among the Three Subgroups in the MM Group and in the TMJ Group.
Trauma Grouping
No stressor
Negative
Positive
Chi
MPI profile
PTSD
PTSD
square

p

MM Group
Dysfunctional

25 (36.8)

12 (27.9)

9 (42.9)

9.440

.009*

Interpersonally distressed

11 (16.2)

10 (23.3)

6 (28.6)

1.556

.459

Adaptive coper

32 (47.1)

21 (48.8)

6 (28.6)

17.320

.000*

Dysfunctional

7 (15.2)

7 (25.9)

7 (58.3)

0.000

1.00

Interpersonally distressed

6 (13.0)

2 (7.4)

2 (16.7)

3.200

.202

Adaptive coper

33 (71.7)

18 (66.7)

3 (25.0)

25.00

.000*

TMJ group

MPI: .Multidimensional Pain Inventory:
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
N: Number of patients; %: percentage.
PTSD: Post-traumatic Stress Disorder.
*: Statistically significant
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Table 13 Comparisons of MPI Profile Classification between MM and TMJ Group on the Subgroup Level.
MPI profile
Trauma Grouping
MM Group
TMJ Group
Chi-square
p
N (%)
N (%)
Dysfunctional
No stressor
25 (19.8)
7 (6.2)
10.125
.001*

Interpersonally distressed

Adaptive coper

Negative PTSD

12 (15.0)

7 (10.0)

1.316

.251

Positive PTSD

9 (25.0)

7 (35.0)

.250

.617

No stressor

11 (8.7)

6 (5.3)

1.417

.225

Negative PTSD

10 (12.5)

2 (2.9)

5.330

.021*

Positive PTSD

6 (16.7)

2 (10.0)

2.000

.157

No stressor

32 (25.4)

33 (29.2)

.015

.901

Negative PTSD

21 (26.3)

18 (25.7)

.231

.631

Positive PTSD

6 (16.7)

3 (15.0)

1.000

.317

MPI: .Multidimensional Pain Inventory:
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
N: Number of patients; %: percentage.
PTSD: Post-traumatic Stress Disorder.
*: Statistically significant.
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Table 14. PSQI Means and Standard Deviation between the MM and TMJ Group.
PSQI Scales

MM group
M (SD)
1.6 (0.8)

TMJ group
M (SD)
1.3 (0.8)

F

p

13.228

.000*

Sleep latency

1.6 (1.0)

1.3 (1.0)

10.114

.002*

Sleep duration

1.3 (1.0)

1.1 (1.0)

5.370

.021*

Habitual sleep efficiency

1.0 (1.1)

0.7 (1.0)

6.774

.010*

Sleep disturbances

1.8 (0.6)

1.6 (0.6)

9.114

.003*

Use of sleep medication

1.4 (1.4)

0.9 (1.2)

15.359

.000*

Daytime dysfunction

1.3 (0.8)

1.1 (0.8)

6.046

.014*

PSQI total score

10.0 (4.4)

8.0 (4.2)

22.346

.000*

Subjective sleep quality

PSQI: Pittsburgh Sleep Quality Index.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
M: Mean; SD: Standard Deviation.
*: Statistically significant.
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Table 15. PSQI Means and Standard Deviations among the Three Subgroups in the MM group.
No stressor
M (SD)
Subjective sleep quality
Sleep latency

1.6 (0.9)
a

1.6 (1.0)
a

Sleep duration

1.2 (0.9)

Habitual sleep efficiency

0.9 (1.1)
a

Negative
PTSD
M (SD)
1.5 (0.8)
a

1.5 (1.0)
a, b

1.4

(1.0)

1.0 (1.1)
a

Positive PTSD
M (SD)

F

p

1.9 (0.8)

2.315

.101

6.339

.002*

1.7 (1.1)

3.045

.050*

1.5 (1.9)

2.842

.060

b

2.2 (0.9)
b

b

Sleep disturbances

1.7 (0.6)

1.7 (0.6)

2.2 (0.6)

9.063

.000*

Use of sleep medication

1.3 (1.4)

1.3 (1.3)

1.7 (1.4)

Daytime dysfunction
PSQI total score

a

1.3 (0.8)
a

9.7 (4.4)

a

1.2 (0.7)
a

9.6 (4.4)

.738

.479

b

6.326

.002*

b

7.871

.000*

1.8 0.8)
13.0 (4.0)

PSQI: Pittsburgh Sleep Quality Index.
MM: Masticatory Muscle; M: Mean; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
ab
When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between
group means at p≤.05
*: Statistically significant
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Table 16. PSQI Means and Standard Deviations among the Three Subgroups in the TMJ Group.
No stressor
M (SD)
Subjective sleep quality
Sleep latency

1.2a (0.8)
a

1.2 (1.0)
a

Negative
PTSD
M (SD)
1.4a (0.8)
a

1.3 (1.0)
a

Positive PTSD
M (SD)

F

p

1.9 b (0.9)

6.529

.002*

b

5.204

.006*

b

2.0 (1.1)

Sleep duration

1.1 (0.9)

0.9 (0.9)

1.8 (1.2)

5.772

.004*

Habitual sleep efficiency

a
0.7 (1.0)

0.5a (0.9)

1.5b (1.3)

5.619

.004*

b

10.435

.000*

b

3.437

.034*

b

10.200

.000*

13.611

.000*

Sleep disturbances
Use of sleep medication
Daytime dysfunction
PSQI total score

a

1.5 (0.6)
a

0.7 (1.1)
a

1.0 (0.8)
a

7.4 (4.0)

a

1.6 (0.6)
a, b

1.0

(1.3)

a

1.0 (0.8)
a

7.9 (3.8)

2.2 (0.6)
1.4 (1.4)
1.9 (0.8)
b

13.0 (4.4)

PSQI: Pittsburgh Sleep Quality Index.
TMJ: Temporomandibular Joint; M: Mean; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
ab
When superscripts are the same between 2 groups , post-hoc comparisons indicates no significant differences
between group means. When superscripts are different, post-hoc comparisons indicate significant difference between
group means at p≤.05
*: Statistically significant
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Table 17. Comparison of PSQI scales between MM and TMJ Group on the Subgroup Level.

Subjective sleep quality

Sleep latency

Sleep duration

Habitual sleep efficiency

Sleep disturbances

Use of sleep medication

Daytime dysfunction

PSQI total score

MM group
M (SD)
1.6 (0.9)

TMJ group
M (SD)
1.2 (0.8)

F
13.242

p
.000*

Negative PTSD

1.5 (0.8)

1.4 (0.8)

1.601

.208

Positive PTSD

1.9 (0.8)

1.9 (0.9)

.001

.976

No stressor

1.6 (1.0)

1.2 (1.0)

8.687

.004*

Negative PTSD

1.5 (1.0)

1.3 (1.0)

.987

.322

Trauma grouping
No stressor

Positive PTSD

2.2 (0.9)

2.0 (1.1)

.390

.535

No stressor

1.2 (0.9)

1.1 (0.9)

.714

.399

Negative PTSD

1.4 (0.9)

0.9 (0.9)

8.361

.004*

Positive PTSD

1.7 (1.1)

1.8 (1.2)

.063

.803

No stressor

0.9 (1.1)

0.7 (1.0)

1.735

.189

Negative PTSD

1.0 (1.1)

0.5 (0.9)

6.804

.010*

Positive PTSD

1.4 (1.9)

1.4 (1.3)

.000

.992

No stressor

1.7 (0.6)

1.5 (0.6)

9.011

.003*

Negative PTSD

1.7 (0.6)

1.6 (0.6)

.544

.462

Positive PTSD

2.2 (0.6)

2.7 (0.6)

.157

.694

No stressor

1.3 (1.4)

0.7 (1.1)

15.097

.000*

Negative PTSD

1.3 (1.3)

1.0 (1.3)

1.626

.204

Positive PTSD

1.7 (1.4)

1.4 (1.4)

.418

.521

No stressor

1.3 (0.8)

1.0 (0.8)

5.569

.019*

Negative PTSD

1.2 (0.7)

1.0 (0.8)

1.224

.270

Positive PTSD

1.8 (0.8)

1.9 (0.8)

.413

.524

No stressor

9.7 (4.4)

7.4 (4.0)

15.972

.000*

Negative PTSD

9.6 (4.1)

7.9 (3.8)

6.559

.011*

Positive PTSD

13.0 (4.0)

12.7 (4.0)

.058

.810

PSQI: Pittsburgh Sleep Quality Index.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
M: Mean; SD: Standard Deviation.
PTSD: Post-traumatic Stress Disorder.
*: Statistically significant.
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Fig. 1. SCL-90-R Scores by Masticatory Muscle & Temporomandibular Joint Group.

TMJ Group (n=202)

SCL-90-R: Symptom Check List- 90-Revised.
T-score ≥ 63: levels indicative of psychological dysfunction.
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;
PAR: paranoid ideation, PSY: psychoticism.
MM: Masticatory Muscle; TMJ: Temporomandibular Joint.
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Figure 2. SCL-90-R Score by PTSD Status in the Masticatory Muscle Group.

Pos PTSD sym ptom s

SCL-90-R: Symptom Check List- 90-Revised.
PTSD: Post-traumatic Stress Disorder.
T-score ≥ 63: levels of indicative psychological dysfunction.
Neg: negative; Pos: positive.
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;
PAR: paranoid ideation, PSY: psychoticism.
*: Post-hoc comparisons indicate significant difference between the “positive PTSD symptoms” and the other two
subgroups (p=.000).
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Figure3. SCL-90-R Score by PTSD Status in the Temporomandibular Joint Group.

Pos PTSD sym ptom s

SCL-90-R: Symptom Check List- 90-Revised.
PTSD: Post-traumatic Stress Disorder.
T-Score ≥ 63: levels indicative psychological dysfunction.
Neg: negative; Pos: positive.
SOM: somatization; OC: obsessive-compulsive; IS: interpersonal sensitivity;
DEP: depression; ANX: anxiety; HOS: hostility; PhANX: phobic anxiety;
PAR: paranoid ideation, PSY: psychoticism.
*: Post-hoc comparisons indicate significant difference between the “positive PTSD symptoms” and the other two
subgroups (p=.000)
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Chapter 6. Discussion

Post-traumatic Stress Disorder symptoms were reported by 14.9% of
patients with MM pain and by 9.9% of patients with TMJ pain. Analyses of the
total sample revealed an overall prevalence of 12.6% for PTSD symptoms. The
findings of this study are in agreement with previous studies in orofacial pain
populations 7,

19

. In a recent investigation, de Leeuw et al

19

reported an overall

prevalence rate of 14.7 % for PTSD symptoms in orofacial pain patients. Similar
to previous studies, we observed a higher prevalence rate of PTSD symptoms in
MM pain patients when compared to TMJ/intracapsular pain patients

19 26

,

. The

higher prevalence of PTSD symptoms in the MM group is not surprising given
that several studies reported higher levels of psychological distress in MM pain
patients than in TMJ pain patients

15

,

14 17

,

. Moreover, studies have shown that

MM pain patients report more exposures to stressful life events than TMJ pain
patients 20,35.
Surprisingly, the overall prevalence rate of 12.6% of PTSD symptoms was
similar to the lifetime prevalence of PTSD (1% to 14%) in the general population
estimated by the DSM-IV 1. Current PTSD prevalence rates, however, appear to
be less than 10%

126 127 128

,

,

. Given these data, the prevalence of current PTSD

symptomatology in the present study can be considered somewhat elevated.
Nevertheless, our findings disagree with previous studies in chronic pain
(fibromyalgia), where extremely elevated prevalence rates (approximately 55%)
of PTSD symptoms have been reported 4, 5. Such discrepancy could potentially
be explained by individual differences among these study populations, such as
54

social support, family history, personality variables and preexisting mental
disorders that may be involved in the development of PTSD 1, or methodological
differences between the studies. On the other hand, the discrepancy between
our studies and these other two studies could be a reflection of an increased
vulnerability for PTSD symptoms in patients with chronic widespread pain
conditions when compared to patients with a more localized pain condition such
as TMD. Further studies are needed to clarify whether such relationship exists.
Previous studies have shown a relationship between the presence of
PTSD symptoms and increased pain level 4,

18

. We were unable to confirm this

relationship because in the present study there was no significant difference for
both MM and TMJ among the PTSD subgroups in regard to pain severity. Such
conflicting findings could potentially be explained due to methodological
differences or different pain populations between this study and the previous
studies. On the other hand, in accordance with these studies and two other
studies in orofacial pain populations 8,

19

the present study indicates a positive

relationship between PTSD symptoms and disability. Sharp et al in 2001
described a model to explain the overlap of symptoms between chronic pain and
PTSD, the mutual maintenance hypothesis, whereby chronic pain and PTSD
may reciprocally maintain or exacerbate the symptoms of both conditions that
may lead to disability

101

. Nonetheless, a causal relationship between PTSD and

disability can not be established with the present study due to its retrospective
nature; further studies are need to determine whether such relationship exist.

55

The SCL-90-R data revealed somewhat higher scores for patients in the
MM group than for patients in the TMJ group. An interesting finding of this study
was that only TMD patients (both of the MM group and TMJ group) with PTSD
symptomatology presented with elevated levels of psychological dysfunction (Tscore ≥ 63) on the SCL-90-R. Evidence suggests that scores equal or greater
than 63 are considered by most authors as the “cut-off” point for clinical
significance
al

19

129

. Our findings are consistent with those presented by de Leeuw et

. They observed that higher levels of psychological distress were limited to

TMD patients who met criteria for PTSD symptomatology. Our findings are also
similar to previous studies with headache

98

and neuropathic pain patients

99

where elevated levels of psychological distress were also linked to only patients
meeting criteria for PTSD symptoms. These findings differ from those of previous
studies, suggesting that MM pain patients report more psychological distress in
general than TMJ pain patients

14 15

,

. The discrepancy between our findings and

the findings reported by these previous studies could be explained by the fact
that these studies did not screen for PTSD symptomatology. Furthermore, this
study contradicts the widely held concept that TMD patients are in general
psychologically distressed. According to our findings, high levels of psychological
dysfunction as measured on the SCL-90-R are likely to be associated with the
presence of PTSD symptoms and not likely to be associated with TMD patients
in general. Consequently, elevated SCL-90-R scores generally may indicate the
presence of PTSD symptoms.

56

Significant differences were found between the MM and TMJ groups on
most scales of the MPI. Our results are in agreement with previous studies of
TMD patients that indicate higher levels of psychological distress and life
interference in muscle pain patients than in TMJ pain patients

15 17 63 130

,

,

,

. The

fact that patients in the MM group presented with more life interference and
higher levels of affective distress than patients in the TMJ group could potentially
be a consequence of how high levels of psychological distress may interfere with
a patient’s coping skills. However, it is not possible to determine whether such an
association exists with the present study; further studies are needed to elucidate
this matter. It is noteworthy that no significant differences were found between
the two diagnostic groups in the “positive PTSD symptoms” subgroups on the
MPI scales. These findings are consistent with those findings reported by de
Leeuw et al

19

. It is remarkable that TMJ pain patients potentially exhibited

deficient coping skills and present with decreased level of social activities when
the presence of PTSD is considered. Indeed, the severity of anxiety and life
interference may be associated with the severity of PTSD symptoms in chronic
pain patients generally

23

. Taken together, these findings further support the

necessity for PTSD screening among TMD patients.
It appears that symptoms of PTSD may potentially interfere with patient’s
capacity to cope with her/his pain. This finding is also reflected in the fact that
dysfunctional MPI profiles were more common than the adaptive coper profile
amongst patients with PTSD symptomatology. Our results are in accordance with
those reported in chronic pain patients with PTSD symptomatology 4,

57

19 100

,

who

also presented more often with a dysfunctional profile than an adaptive coper
profile. In addition, dysfunctional profiles may be associated with higher levels of
anxiety 100 which, in turn, may potentially exacerbate the pain condition.
A potential explanation for these findings is the dysregulation of the HPAaxis that has been associated with inadequate coping strategies

50

. Alteration in

the physiology of the HPA-axis may be related to somatic complaints such as
myalgia, arthralgia and sleep disturbances in the absence of recognized
pathological condition

131

. In addition, early life events, such as preterm birth,

parental divorce, or childhood abuse may result in physiological vulnerability
expressed as persistent sensitization of the HPA-axis

46

. In fact, dysregulation of

the HPA-axis has also been linked to the development of both chronic pain
and PTSD, that is characterized by maladaptive behavior

132

13 50

,

. In turn, this

maladaptive behavior can be understood as a lack of inhibitory control 133.
Living systems are described as “self-organizing dynamic systems” that
combine autonomic, attentional and affective systems into a functional and
structural network

133 134

,

. These systems are likely to be controlled by inhibitory

processes that allow them the necessary flexibility for efficient functioning
through self-regulation and adaptability of the organism in the face of changing
environmental demands

133 134

,

. Thayer and Lane in 2000 described how arousal

associated with anxiety represents a dis-inhibition of circuits that are normally
under inhibitory control

134

. Thus inhibitory failure may lead to maladaptive

behavior at multiple levels of the organism which, in turn, may prevent recovery
or a return to normal functioning.

58

Several studies have demonstrated a relationship between chronic pain
and sleep disturbances

17 30

, ,

135

. In agreement with previous studies

17

,

64

, our

findings revealed that the patients in the MM group reported more sleep
problems than patients in the TMJ group. It is unlikely that these findings would
30

be a consequence of increased pain severity

or increased pain duration

16

since in the current study no significant differences in regard to pain severity and
duration were found between the two groups. A possible explanation for these
findings could be the presence of psychological distress that has been
associated with sleep disturbances pathogeneses in a number of studies
136

30

,

64

,

.
Both MM and TMJ pain patients in the “positive PTSD symptoms”

subgroup reported more sleep problems on most scales of the PSQI than MM
and TMJ pain patients in the “no stressor” and in the “negative PTSD symptoms”
subgroups. This finding is not extraordinary if the presence of PTSD symptoms is
considered. Indeed, according to the DSM-IV

1

sleep disturbances are included

in the symptomatology of PTSD. It is not possible to determine with the present
study design whether the sleep disturbances were a response to the pain
experience itself or whether they were associated to the symptomatology of
PTSD. These findings may be associated to an overlap of symptoms between
chronic pain and PTSD symptoms

23

,

101

which in turn may exacerbate the

symptomatology of both conditions. On the other hand, it also could be a
response to alterations of HPA-axis, a common characteristic found in chronic
pain patients as well as in PTSD patients

59

46

. Indeed, the HPA-axis plays

important roles in maintaining alertness and modulating sleep

137

. In addition,

dysregulation of the HPA-axis has been associated with sleep disturbances in a
number of studies

50

,

138

. Nonetheless, sleep disturbances are remarkably

common in chronic pain and in PTSD and should be addressed since it could be
a major factor in chronic pain and PTSD symptomatology.
Given

the

coexistence

of

chronic

pain

and

PTSD,

appropriate

management of chronic pain patients with symptoms of PTSD may possibly
require treatment of both the anxiety disorder and the pain disorder. There are
only a small number of studies addressing treatment outcomes in chronic pain
patients with PTSD symptoms

116

,

117

. Research suggests favorable treatment

outcomes targeting symptoms of PTSD in chronic pain patients such as
decreased PTSD symptomatology and improvement in dysfunction associated to
pain

117

. The fact that in the present study, TMD patients with PTSD

symptomatology were more often classified with a dysfunctional profile than an
adaptive coper profile may further complicate interventions in such patients.
Indeed, a dysfunctional profile has been related to poor treatment outcome
overall in TMD patients and to treatment failure 15. In addition, failure to recognize
psychological distress has been associated with poor treatment response

114

and

prematurely abandoning treatment 115. It is likely that for successful treatment the
multiple coexisting factors need to be addressed. Indeed, targeting PTSD
symptoms may be a key factor in managing chronic pain patients with such
symptomatology. Unfortunately, our study was not designed to evaluate
treatment outcomes, although we acknowledge the need for well designed

60

longitudinal studies to answer questions such as whether management of PTSD
would change treatment outcomes for chronic pain.
The present study has limitations due its retrospective design. It is not
possible to determine a causal relationship between chronic pain and PTSD. It is
also not possible to determine causal relationships among chronic pain, PTSD
and psychological distress as well as among chronic pain, PTSD and sleep
disturbances. An additional limitation is that this survey was conducted with
patients who sought treatment for their TMD problem in a tertiary care center
which could overestimate the prevalence rate of PTSD and the relationships
among PTSD, psychological distress and sleep disturbances found in the present
study as compared to what occurs in the natural environment. Given that the
patients in this study could represent a more skewed pain population compared
to the typical patients seem at a general practice. On the other hand, we
implemented strict inclusion criteria in each diagnostic group (MM and TMJ
group) whereby only patients with primary and when given a secondary
diagnosis of MM pain (MM group) or TMJ pain (TMJ group) were included in
order to have a more accurate sample. These inclusion criteria probably
strengthen our findings given that our sample would be more representative of a
more precise MM pain and TMJ pain population and thus decreasing the
likelihood for potential errors associated with differential diagnosis.

Copyright © 2005, Elizangela Bertoli
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Chapter 7. Conclusion
The present study replicates and extends previous investigations
addressing the relationship between chronic pain and PTSD symptoms.
Approximately 13% of patients reporting to an Orofacial Pain Clinic met criteria
for PTSD symptomatology. A higher prevalence rate of PTSD symptoms was
detected for patients in the MM group (14.9%) as compared to patients in the
TMJ group (9.9%). This difference was not statistically significant; consequently,
our primary hypothesis that the prevalence of PTSD symptoms would be higher
for patients in the MM group than for patients in the TMJ group was not
confirmed. There was, however, a trend suggesting a higher prevalence of PTSD
symptomatology in the MM group when compared to the TMJ group. Analysis of
our findings revealed that psychological distress measured on both SCL-90-R
and MPI and sleep disturbances measured on the PSQI were linked to PTSD
symptomatology in both MM and TMJ group. We also found that MM pain
patients presented with more life interference, affective distress and sleep
disturbances, and less life control than TMJ pain patients confirming and
expanding previous studies addressing the differences between MM and TMJ
pain patients. However, when the presence of PTSD was considered these
differences

were

mostly

maintained

in

the

subgroups

without

PTSD

symptomatology. Hence, the presence of PTSD appears to modulate not only the
level of psychological distress in TMD patients and sleep disturbances, but also
the differences between MM and TMJ groups. Further longitudinal research is

62

necessary to explore the relationship between chronic pain and PTSD patients
and to devise effective multidimensional treatment.

Copyright © 2005, Elizangela Bertoli
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